Role of meteorin-like in the immune system

陨石蛋白样在免疫系统中的作用

基本信息

  • 批准号:
    9398097
  • 负责人:
  • 金额:
    $ 18.41万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-12-13 至 2018-11-30
  • 项目状态:
    已结题

项目摘要

Through bioinformatics analyses of a comprehensive database of gene expression (Body Index of Gene Expression (BIGE)), we sought to identify novel/uncharacterized genes associated with the immune system. We identified a poorly characterized secreted protein expressed by activated macrophages encoded by a gene currently identified as ‘meteorin-like’ (metrnl). This gene is strongly expressed in barrier tissues (skin, mucosa) and by activated macrophages. Metrnl encodes a small secreted protein of 311 aminoacids with a 45 aminoacid signal peptide, predicting a mature protein of 266 aminoacids, with an estimated molecular weight of ~29KDa. It is expressed in human peripheral blood monocytes or mouse peritoneal macrophages following activation and its expression is modulated (positively or negatively) by various cytokines. We have produced a Metrnl/IL-39-/- mouse which is viable and breeds well, but exhibits various immune system defects. Taken together, we conclude that Metrnl represents a novel cytokine for which we recommend the name interleukin 39 (IL-39). Metrnl/IL-39 is overexpressed in psoriasis and rheumatoid arthritis, suggesting a role in human inflammatory/autoimmune diseases. Metrnl/IL-39 expression is also induced in the peritoneum of mice injected with thioglycollate, consistent with a role in inflammation. The immune system abnormalities we have detected in the Metrnl/Il-39-/- mouse, include lower serum IgG levels, which are due to very low levels of IgG2b and IgG3. Furthermore, its splenocytes exhibit altered cytokine production, including inability to produce some chemokines (CCL3) as well as significantly lower levels of IFN. These observations strongly support our conclusion that Metrnl/IL-39 represents a novel cytokine involved in immunoregulation. Metrnl/IL-39 has been reported to induce the expression of the nuclear receptor PPAR in adipocytes, but its effects on cells of the immune system are unknown. In Specific Aim 1, we will identify cells of the immune system that express the Metrnl/IL-39 receptor based on the ability of Metrnl/IL-39 to induce the expression of PPAR, or to bind biotinylated Metrnl/IL-39 (detected by FACS). We will also explore whether the B cell defects observed in the Metrnl/IL-39-/- mouse (very low IgG2b and IgG3) are due to defective class switching in B cells, and will explore a potential role for Metrnl/IL-39 in the polarization of naïve T cells to the Th1, Th2, Th17 and iTreg stages. We have also observed that the Metrnl/IL-39-/- mouse is highly susceptible to Toxoplasma gondii. In Specific Aim 2, we will explore several immune mechanisms that may account for this increased susceptibility to T. gondii. We will study the ability of Toxoplasma to grow in monocytes from Metrnl/IL-39 or wild type (WT) mice, and will also monitor Th1, Th2 or Th17 cytokine levels in Metrnl/IL-39-/- or WT mice during infection. We will finally determine whether administration of Metrnl/IL-39 can reverse the susceptibility observed in the Metrnl/IL-39-/- mouse to T. gondii. Through these studies we will validate the hypothesis that Metrnl/IL-39 represents a novel cytokine associated with the immune system and inflammation and will open a new field of research.
通过对基因表达综合数据库(基因身体指数)的生物信息学分析 表达(BigE)),我们试图识别与免疫系统相关的新的/未鉴定的基因。 我们发现了一种由激活的巨噬细胞表达的分泌蛋白,该蛋白由一种基因编码 目前已被鉴定为“类陨星”(Metrnl)。该基因在屏障组织(皮肤、粘膜)中强烈表达。 和被激活的巨噬细胞。Metrn1编码一种由311个氨基酸组成的分泌蛋白,编码45个氨基酸。 氨基酸信号肽,预测一个由266个氨基酸组成的成熟蛋白质,估计其相对分子质量 大约29 KDa。它在人外周血单核细胞或小鼠腹膜巨噬细胞中表达 激活及其表达受各种细胞因子的调节(正向或负向)。我们已经制作了 Metrnl/IL-39-/-小鼠是一种活的,繁殖良好,但表现出各种免疫系统缺陷的小鼠。已被占用 总之,我们得出结论,Metrnl代表一种新的细胞因子,我们推荐将其命名为IL 39(IL-39)。Metrn1/IL-39在银屑病和类风湿关节炎中过表达,提示在人类 炎症性/自身免疫性疾病。注射的小鼠腹膜中也可诱导Metrn1/IL-39的表达 含有硫代乙醇酸盐,与炎症作用一致。我们检测到的免疫系统异常 在Metrnl/Il-39-/-小鼠中,包括较低的血清免疫球蛋白水平,这是由于非常低的IgG2b和 IgG3。此外,它的脾细胞表现出细胞因子产生的改变,包括不能产生一些 趋化因子(CCl_3)和干扰素水平显著降低。这些观察结果有力地支持了我们的 结论Metrnl/IL-39是一种参与免疫调节的新细胞因子。Metrnl/IL-39已经 据报道可诱导脂肪细胞核受体PPAR的表达,但其对细胞的影响 免疫系统是未知的。在特定的目标1中,我们将识别免疫系统中表达 基于Metrn1/IL-39受体诱导PPAR表达或结合能力的研究 生物素标记的Metrnl/IL-39(FACS检测)。我们还将探索在B细胞缺陷中观察到的 Metrnl/IL-39-/-小鼠(非常低的IgG2b和IgG3)是由于B细胞类转换缺陷所致,并将探索 Metrn1/IL-39在初始T细胞向Th1、Th2、Th17和iTreg阶段极化中的潜在作用我们 也观察到Metrnl/IL-39-/-小鼠对弓形虫高度敏感。以特定的目标 2,我们将探索几种可能解释弓形虫易感性增加的免疫机制。 我们将研究弓形虫在Metrnl/IL-39或野生型(WT)小鼠单核细胞中的生长能力,以及 还将监测感染期间Metrnl/IL-39-/-或WT小鼠的Th1、Th2或Th17细胞因子水平。我们最终会 确定给予Metrnl/IL-39是否可以逆转Metrnl/IL-39-/-的敏感性 老鼠对弓形虫的感染。通过这些研究,我们将验证Metrnl/IL-39代表一种新的 细胞因子与免疫系统和炎症相关,将开辟一个新的研究领域。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Albert Zlotnik其他文献

Albert Zlotnik的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Albert Zlotnik', 18)}}的其他基金

Role of meteorin-like in the immune system
陨石蛋白样在免疫系统中的作用
  • 批准号:
    9227004
  • 财政年份:
    2016
  • 资助金额:
    $ 18.41万
  • 项目类别:
Functional characterization of IL-40, a novel cytokine
新型细胞因子 IL-40 的功能表征
  • 批准号:
    8872593
  • 财政年份:
    2015
  • 资助金额:
    $ 18.41万
  • 项目类别:
Characterization of CCL28,CXCL14, and CXCL17, three mucosal chemokines
三种粘膜趋化因子 CCL28、CXCL14 和 CXCL17 的表征
  • 批准号:
    8392254
  • 财政年份:
    2011
  • 资助金额:
    $ 18.41万
  • 项目类别:
Characterization of IL36, a novel cytokine
新型细胞因子 IL36 的表征
  • 批准号:
    8264156
  • 财政年份:
    2011
  • 资助金额:
    $ 18.41万
  • 项目类别:
Characterization of CCL28,CXCL14, and CXCL17, three mucosal chemokines
三种粘膜趋化因子 CCL28、CXCL14 和 CXCL17 的表征
  • 批准号:
    8235704
  • 财政年份:
    2011
  • 资助金额:
    $ 18.41万
  • 项目类别:
Characterization of CCL28,CXCL14, and CXCL17, three mucosal chemokines
三种粘膜趋化因子 CCL28、CXCL14 和 CXCL17 的表征
  • 批准号:
    8586295
  • 财政年份:
    2011
  • 资助金额:
    $ 18.41万
  • 项目类别:
Characterization of CCL28,CXCL14, and CXCL17, three mucosal chemokines
三种粘膜趋化因子 CCL28、CXCL14 和 CXCL17 的表征
  • 批准号:
    8971946
  • 财政年份:
    2011
  • 资助金额:
    $ 18.41万
  • 项目类别:
Characterization of IL36, a novel cytokine
新型细胞因子 IL36 的表征
  • 批准号:
    8174696
  • 财政年份:
    2011
  • 资助金额:
    $ 18.41万
  • 项目类别:
Characterization of CCL28,CXCL14, and CXCL17, three mucosal chemokines
三种粘膜趋化因子 CCL28、CXCL14 和 CXCL17 的表征
  • 批准号:
    8774573
  • 财政年份:
    2011
  • 资助金额:
    $ 18.41万
  • 项目类别:
Functional Characterization of CXCL14, CXCL17, and CCL28; three mucosal chemokine
CXCL14、CXCL17 和 CCL28 的功能表征;
  • 批准号:
    7707125
  • 财政年份:
    2009
  • 资助金额:
    $ 18.41万
  • 项目类别:

相似海外基金

Deciphering the role of adipose tissue in common metabolic disease via adipose tissue proteomics
通过脂肪组织蛋白质组学解读脂肪组织在常见代谢疾病中的作用
  • 批准号:
    MR/Y013891/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.41万
  • 项目类别:
    Research Grant
ESTABLISHING THE ROLE OF ADIPOSE TISSUE INFLAMMATION IN THE REGULATION OF MUSCLE MASS IN OLDER PEOPLE
确定脂肪组织炎症在老年人肌肉质量调节中的作用
  • 批准号:
    BB/Y006542/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.41万
  • 项目类别:
    Research Grant
Canadian Alliance of Healthy Hearts and Minds: Dissecting the Pathways Linking Ectopic Adipose Tissue to Cognitive Dysfunction
加拿大健康心灵联盟:剖析异位脂肪组织与认知功能障碍之间的联系途径
  • 批准号:
    479570
  • 财政年份:
    2023
  • 资助金额:
    $ 18.41万
  • 项目类别:
    Operating Grants
Determinants of Longitudinal Progression of Adipose Tissue Inflammation in Individuals at High-Risk for Type 2 Diabetes: Novel Insights from Metabolomic Profiling
2 型糖尿病高危个体脂肪组织炎症纵向进展的决定因素:代谢组学分析的新见解
  • 批准号:
    488898
  • 财政年份:
    2023
  • 资助金额:
    $ 18.41万
  • 项目类别:
    Operating Grants
Activation of human brown adipose tissue using food ingredients that enhance the bioavailability of nitric oxide
使用增强一氧化氮生物利用度的食品成分激活人体棕色脂肪组织
  • 批准号:
    23H03323
  • 财政年份:
    2023
  • 资助金额:
    $ 18.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of new lung regeneration therapies by elucidating the lung regeneration mechanism of adipose tissue-derived stem cells
通过阐明脂肪组织干细胞的肺再生机制开发新的肺再生疗法
  • 批准号:
    23K08293
  • 财政年份:
    2023
  • 资助金额:
    $ 18.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A study on the role of brown adipose tissue in the development and maintenance of skeletal muscles
棕色脂肪组织在骨骼肌发育和维持中作用的研究
  • 批准号:
    23K19922
  • 财政年份:
    2023
  • 资助金额:
    $ 18.41万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Adipose Tissue T Cell Polarization and Metabolic Health in Persons Living with HIV
HIV 感染者的脂肪组织 T 细胞极化和代谢健康
  • 批准号:
    10619176
  • 财政年份:
    2023
  • 资助金额:
    $ 18.41万
  • 项目类别:
Estrogen Signaling in the Ventromedial Hypothalamus Modulates Adipose Tissue Metabolic Adaptation
下丘脑腹内侧区的雌激素信号调节脂肪组织代谢适应
  • 批准号:
    10604611
  • 财政年份:
    2023
  • 资助金额:
    $ 18.41万
  • 项目类别:
Obesity and Childhood Asthma: The Role of Adipose Tissue
肥胖和儿童哮喘:脂肪组织的作用
  • 批准号:
    10813753
  • 财政年份:
    2023
  • 资助金额:
    $ 18.41万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了